Gene Query: UBAC1

Dataset Description Geneva Score
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 53.07
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 41.41
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 41.41
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 36.66
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 32.71
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 28.93
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 28.69
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 25.03
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 25.03
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 22.18
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 22.05
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 21.68
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 21.68
Hijacking of stress response machinery by oncogenes in acute leukaemia 21.05
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 21.05
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 20.73
Spliceosomal disruption of the non-canonical BAF complex in cancer 19.7
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 19.34
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 19.34
The pause-initiation limit restricts transcription activation in human cells 18.63
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 17.45
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 16.88
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 16.54
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 15.64
SNHG5 siRNA knock down in HCT116 cells 15.42
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 14.81
Global analysis of enhancer targets: Mosaic-seq 14.8
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 14.78
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 14.71
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 14.69
Transcriptome analysis of SKI knock-out in HL60 cells 14.52
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 14.52
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 13.56
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 13.55
Epigenomic landscape during organ formation in human early embryos 13.17
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 12.47
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 12.35
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 12.35
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 12.24
Neonatal and adult human testis defined at the single-cell level 12.07
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 11.9
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 11.29
RNA sequencing of primary human platelets and in vitro cell lines 11.22
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.91
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.91
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.9
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 10.72
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.55
Genome wide miR-191 target profile determined by RIP and gene expression profiling 10.49
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 10.49
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 10.42
Differentially expressed genes post knock down of lincDUSP26 10.36
RNAseq Study in CC-671 Treated Cal-51 Cells 10.12
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.69
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 9.35
9.28
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.2
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 9.0
Regulation of highly expressed hCINAP on translatome 8.92
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.73
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 8.68
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 8.67
Short and Long RNA sequencing of human mature erythrocytes 8.53
Gene expression profiling of leukemia cells following asparagine depletion 8.43
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 8.29
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 8.29
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 8.28
Glioblastoma stem cells infected by ZIKA virus 8.26
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.24
G-quadruplex structures mark human regulatory chromatin 8.22
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.19
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 8.12
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.96
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.88
Transcriptome analysis of human lung epithelial cells 7.86
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 7.84
Accurate annotation of human protein-coding small open reading frames 7.8
MEIS1 regulates hematopoiesis in hPSCs 7.78
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.73
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.72
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.72
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 7.65
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.59
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 7.57
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 7.56
METTL3 promotes translation in human cancer cells 7.44
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.35
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 7.32
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 7.28
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 7.23
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 7.23
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 7.02
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 7.02
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 6.99
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 6.99
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.99
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.99
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.95
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.94
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.94
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 6.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.82
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.82
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.81
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.79
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 6.54
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 6.54
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.5
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 6.48
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.31
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 6.2
CD73 knockdown effect in pancreatic cancer cell lines 6.18
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 6.17
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 6.14
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.97
Differential gene expression of human melanoma cells [RNA-seq] 5.97
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 5.97
RNA-seq of YB5 cells treated with Proscillaridin A 5.94
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.92
RNA sequencing of human mammary epithelial cells 5.86
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 5.8
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 5.8
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.78
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.78
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.74
Biological effect of chronic mistranslation in mammalian cells 5.74
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 5.73
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.7
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.7
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.64
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.56
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.45
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.4
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.4
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.4
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.36
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.36
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.33
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.33
Survival of pancreatic cancer cells lacking KRAS function 5.28
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.26
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 5.24
PTHrP overexpression in MCF7 cells 5.24
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.22
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.22
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.17
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.15
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.15
Transcriptome of human white and brown adipose tissue biopsies 5.07
Energy Metabolism during Anchorage-Independence 5.04
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 5.04
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 5.02
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.0
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.0
Transcription elongation regulates genome 3D structure 4.95
Selective expression of long non-coding RNAs in a breast cancer cell progression model 4.9
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.89
The Human Testis Cell Atlas via Single-cell RNA-seq 4.89
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 4.89
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.88
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.86
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.85
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 4.81
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 4.79
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 4.78
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.78
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.77
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 4.76
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.67
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.6
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.6
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 4.59
TOP2B disturbed the quality of human oocytes with advanced maternal age 4.57
Tracking of dCas9-methyltransferase footprints 4.55
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.55
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.55
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.54
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.54
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 4.54
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.54
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.52
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.51
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.51
Genome-wide discovery of human splicing branchpoints [RNAse] 4.49
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.47
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.47
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.46
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.43
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.42
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.41
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.41
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 4.41
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 4.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.39
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 4.38
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.37
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.37
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 4.32
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 4.32
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.31
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.31
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 4.31
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.29
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.27
Transcriptome wide analysis of classically and alternatively activated macrophages 4.26
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 4.24
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.24
Transcriptome analysis of virus infected tissues 4.22
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.18
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 4.16
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.15
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.12
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.12
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.12
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 4.1
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 4.1
RNA-seq of IL-4 stimulated human keratinocytes 4.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 4.08
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 4.08
Modeling Human Cancer-induced Cachexia (Human) 4.06
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.05
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.02
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.02
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.01
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.98
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.97
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.97
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.95
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.95
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.95
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.93
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 3.93
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.91
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.91
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 3.89
High-throughput sequencing of pluripotent cells 3.88
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.85
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.85
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.83
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 3.82
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 3.81
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.81
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.81
U1 snRNP telescripting regulates size-function stratified human genome 3.78
Clinker: visualizing fusion genes detected in RNA-seq data 3.76
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.73
Effect of FGF13 depletion on the H460 cell line 3.73
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.73
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 3.72
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 3.67
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.65
RNA-seq of naive and primed ES cells 3.63
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.62
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.62
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.61
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.61
Cell responses to dysregulated VZV-induced cell-cell fusion 3.59
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.58
Targeting MTHFD2 in Acute Myeloid Leukemia 3.58
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.56
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.47
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.47
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.47
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.46
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 3.46
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 3.46
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.43
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 3.43
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 3.42
JAK dependent survival of ALK- ALCL 3.41
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.41
RNA-seq analyisis of PUM2 knockout cells 3.39
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.37
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.29
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.29
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 3.21
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.18
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.17
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 3.16
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.15
Global Mapping of Human RNA-RNA Interactions 3.15
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.15
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 3.14
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.08
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.06
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.05
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.04
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.04
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.02
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.0
NAPRT activation of macrophages 2.98
SRSF1 role in cellular gene expression and splicing 2.96
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 2.94
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 2.94
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.91
The cohesin complex prevents Myc-induced replication stress 2.89
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.85
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.78
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 2.75
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.74
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.73
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.73
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.73
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 2.71
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 2.71
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.7
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.7
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.69
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.66
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.64
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 2.64
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.63
Tpl-2 and MEK small molecule inhibitors 2.63
Tpl-2 small molecule project 2.63
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 2.63
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.62
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.59
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.56
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.56
Genome-wide discovery of human splicing branchpoints 2.54
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 2.51
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.49
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.48
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.48
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.42
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 2.41
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.41
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.41
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.39
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.34
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.34
RNAseq of cell lines with knocked in ESR1 mutations 2.33
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.33
Gene expression analysis in response to hypoxic pathway inhibition 2.33
PRDM1 inhibits proliferation of human colon cancer organoids 2.33
Exploring ILF2 regulatory genes by next-generation sequencing 2.27
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.26
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 2.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.23
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.23
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.22
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.17
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 2.16
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 2.16
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.12
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.12
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.1
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.07
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.07
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.05
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.05
Functional significance of the HIV-1 Tat signature amino acid residues 2.04
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.01
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.0
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.0
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.99
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.97
RNA-seq of RKO cells with cTAZ KO or putback 1.95
SLAM-seq for K562 endogenous mRNA decay 1.92
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.92
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.9
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.9
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.89
Irf9 function in immunity in mouse 1.87
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 1.87
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.83
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.8
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.8
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.8
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.78
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.78
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.71
Specific molecular signatures underlie response to decitabine in CMML 1.71
Single-Cell Genotyping of Transcriptomes 1.7
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.7
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.68
Downregulation of DDX5/DDX17 and REST 1.68
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.67
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.66
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 1.64
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.63
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.61
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.61
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.61
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.59
Human cells contain natural double-stranded RNAs with potential regulatory capacity 1.58
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.57
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.57
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.52
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.52
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.51
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.51
Mapping interactions for the TNIP2 hub protein 1.48
Transcriptome-wide response to synthetic chromatin protein PcTF 1.45
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.44
p63 controls the enhancer landscape during keratinocyte differentiation 1.43
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.43
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.41
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 1.41
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.4
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.36
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.35
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.35
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.34
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.33
Molecular Criteria for Defining the Naive Human Pluripotent State 1.3
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.28
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.27
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.27
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.25
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.24
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.22
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.21
The bromodomain protein BRD4 regulates splicing during heat shock 1.19
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.18
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.17
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.14
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.14
RNA-Seq of PRMT1 overexpression ECA109 cells 1.13
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.12
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.1
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.08
RNA editing in nascent RNA affects pre-mRNA splicing 1.07
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.04
NR2F2 study 1.04
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.03
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.02
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.01
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.0
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.99
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.99
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.98
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.93
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.93
Gene expression changes due to PARP knockdown in human cells 0.92
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.9
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.89
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.88
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.85
miRNAs affected by antagomiR-17 treatment 0.84
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.83
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.83
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.83
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.82
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.82
High-resolution comparative analysis of great ape genomes 0.8
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.79
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.79
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.75
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.74
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.73
Comparative Analysis of Cas9 Activators Across Multiple Species 0.65
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.64
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.59
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.57
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.57
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.55
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.54
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.53
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.51
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.5
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.48
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.47
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.46
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.44
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 0.43
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.43
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.42
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.42
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.42
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.4
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.37
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.33
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.33
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.29
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.24
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.24
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.23
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.23
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.23
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.23
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.23
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.21
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.21
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.21
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.2
Effect of nuclear IL-33 on gene expression 0.19
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.17
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.17
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.15
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.12
The DPYSL2 gene connects mTOR and schizophrenia 0.1
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.08
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.08
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.06
Myc activation coordinates gene transcription and protein translation responses 0.05
Oncogenic roles of ARID5B in T-ALL 0.05
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.05
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation